Read More Pharma Industry News Q32 Bio’s bempikibart shows signs of a remittive effect in alopecia areata—Here’s what that means Q32 Bio Inc. has released promising SIGNAL-AA trial results, shedding new light on the potential of bempikibart clinical… byPallavi MadhirajuMarch 9, 2025